Cargando…

Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus

Staphylococcus aureus is a Gram-positive bacterium that has become the leading cause of hospital acquired infections in the US. Repurposing Food and Drug Administration (FDA) approved drugs for antimicrobial therapy involves lower risks and costs compared to de novo development of novel antimicrobia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajamuthiah, Rajmohan, Fuchs, Beth Burgwyn, Conery, Annie L., Kim, Wooseong, Jayamani, Elamparithi, Kwon, Bumsup, Ausubel, Frederick M., Mylonakis, Eleftherios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405337/ https://www.ncbi.nlm.nih.gov/pubmed/25897961 http://dx.doi.org/10.1371/journal.pone.0124595

Ejemplares similares

Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014)

A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015)

Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy
por: Kim, Wooseong, et al.
Publicado: (2015)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections
por: Marrugal-Lorenzo, José A., et al.
Publicado: (2019)

Pathogenesis of the Candida parapsilosis Complex in the Model Host Caenorhabditis elegans
por: Souza, Ana Carolina Remondi, et al.
Publicado: (2018)

Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2015)

Erratum to: Micafungin Elicits an Immunomodulatory Effect in Galleria mellonella and Mice
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2015)

Effector triggered immunity: Activation of innate immunity in metazoans by bacterial effectors
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014)

Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay
por: Breger, Julia, et al.
Publicado: (2007)

The Role of Candida albicans SPT20 in Filamentation, Biofilm Formation and Pathogenesis
por: Tan, Xiaojiang, et al.
Publicado: (2014)

Anthelmintics for drug repurposing: Opportunities and challenges
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2021)

Repurposing Kinase Inhibitor Bay 11-7085 to Combat Staphylococcus aureus and Candida albicans Biofilms
por: Escobar, Iliana E., et al.
Publicado: (2021)

Selecting an Invertebrate Model Host for the Study of Fungal Pathogenesis
por: Desalermos, Athanasios, et al.
Publicado: (2012)

The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
por: Son, Deok-Soo, et al.
Publicado: (2020)

Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
por: Song, Bomi, et al.
Publicado: (2022)

The Temperature-Sensitive Role of Cryptococcus neoformans ROM2 in Cell Morphogenesis
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2007)

Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive Bacteria
por: Felix, LewisOscar, et al.
Publicado: (2021)

The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus
por: Tharmalingam, Nagendran, et al.
Publicado: (2019)

In the Model Host Caenorhabditis elegans, Sphingosine-1-Phosphate-Mediated Signaling Increases Immunity toward Human Opportunistic Bacteria
por: Lee, Kiho, et al.
Publicado: (2020)

Lipid signalling couples translational surveillance to systemic detoxification in Caenorhabditis elegans
por: Govindan, J. Amaranath, et al.
Publicado: (2015)

Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
por: Hamdoun, Sami, et al.
Publicado: (2017)

Salicylanilides and Their Anticancer Properties
por: Kauerová, Tereza, et al.
Publicado: (2023)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Antimycobacterial Activity of Salicylanilide Benzenesulfonates
por: Krátký, Martin, et al.
Publicado: (2012)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing
por: Weeks, Janis C., et al.
Publicado: (2018)

Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
por: Florio, Rosalba, et al.
Publicado: (2021)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Exploiting Amoeboid and Non-Vertebrate Animal Model Systems to Study the Virulence of Human Pathogenic Fungi
por: Mylonakis, Eleftherios, et al.
Publicado: (2007)

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)

Candida albicans Infection of Caenorhabditis elegans Induces Antifungal Immune Defenses
por: Pukkila-Worley, Read, et al.
Publicado: (2011)

Rapid Isolation and Concentration of Pathogenic Fungi Using Inertial Focusing on a Chip-Based Platform
por: Fuchs, Beth Burgwyn, et al.
Publicado: (2019)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
por: Thangamani, Shankar, et al.
Publicado: (2015)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

In Vitro Antibacterial and Antifungal Activity of Salicylanilide Benzoates
por: Krátký, Martin, et al.
Publicado: (2012)

Antibacterial Activity of Salicylanilide 4-(Trifluoromethyl)benzoates
por: Krátký, Martin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qmmu0mboe7jb2egn5kbkisfbgg